BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25531390)

  • 21. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study.
    Wentzensen N; Wilson LE; Wheeler CM; Carreon JD; Gravitt PE; Schiffman M; Castle PE
    Cancer Res; 2010 Nov; 70(21):8578-86. PubMed ID: 20959485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
    Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
    Sherman ME; Wang SS; Wheeler CM; Rich L; Gravitt PE; Tarone R; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1038-44. PubMed ID: 14578140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
    Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
    Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
    Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
    J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
    Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T
    PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in type-specific human papillomavirus load predict progression to cervical cancer.
    Depuydt CE; Criel AM; Benoy IH; Arbyn M; Vereecken AJ; Bogers JJ
    J Cell Mol Med; 2012 Dec; 16(12):3096-104. PubMed ID: 22978795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
    Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
    AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Kermorgant S; Daraï E; Madelenat P; Cremieux AC; Hénin D; Lehy T
    Clin Cancer Res; 2003 Jan; 9(1):273-84. PubMed ID: 12538480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
    Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
    Zuna RE; Wang SS; Schiffman M; Solomon D
    Cancer; 2006 Oct; 108(5):288-97. PubMed ID: 16952155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.